RxDoctor Payments Data

Zaheer Ahmed

Adolescent Medicine · Brooklyn, NYNPI 1609189653

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Merck at 26.2% of the total.

$1,849in general payments, 2019–2025

Across 82 payments — averaging $22.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$485
  • GSK$389
  • Pfizer$205
  • Boehringer Ingelheim$152
  • Amneal Pharmaceuticals LLC$110
  • Kowa Pharmaceuticals America, Inc.$110
  • plus $398 from 13 others

What the payments were for

  • Food & beverage$1,81498%
  • Education$352%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,849 in reported general payments places this provider in the 85th percentile of 257 adolescent medicine providers in New York.

See all adolescent medicine providers in New York

Other adolescent medicine in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →